Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...

By Arasu Kannagi Basil (Reuters) -Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial public offering, set to be the first U.S.

Maze Therapeutics is eyeing a $113 million initial public offering a little under two months after revealing a $115 million ...

An international team of scientists have discovered that soap could be important to helping our understanding of complex ...

An anonymous coder, writing to 404media under the fake name Aaron B, has also been feeling the malaise, and he's doing ...

Lines of tractors have taken to roads across Northern Ireland to protest against proposed changes to inheritance tax rules.

BYD shared a video showing the YangWang U7 leveraging the Disus-Z suspension system to complete a maze game via phone control ...

In the last few years, researchers have found that surfactants—the molecules found in soap—can naturally find its way through a maze using the shortest path, with little penetration into dead ...